Home Newsletters Mammary Cell News PRMT5 Regulates RNA M6A Demethylation for Doxorubicin Sensitivity in Breast Cancer

PRMT5 Regulates RNA M6A Demethylation for Doxorubicin Sensitivity in Breast Cancer

0
Scientists found that doxorubicin treatment significantly induced RNA m6A methylation in breast cancer cells in both a dose- and time-dependent manner.
[Molecular Therapy]
6445212 AAAAAAAA items 1 apa 0 default asc 1 172984 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
AbstractGraphical Abstract
Exit mobile version